Sterling Capital Management LLC Krystal Biotech, Inc. Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
A detailed history of Sterling Capital Management LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 25 shares of KRYS stock, worth $4,605. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25Holding current value
$4,605% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KRYS
# of Institutions
291Shares Held
24.9MCall Options Held
270KPut Options Held
177K-
Black Rock Inc. New York, NY3.95MShares$727 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.85MShares$525 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.62MShares$483 Million7.18% of portfolio
-
State Street Corp Boston, MA1.45MShares$268 Million0.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA988KShares$182 Million10.7% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.73B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...